Melatonin News and Research

RSS

Melatonin, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants, and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions.

Exposure to light at night renders breast cancer completely resistant to drug

Exposure to light at night, which shuts off nighttime production of the hormone melatonin, renders breast cancer completely resistant to tamoxifen, a widely used breast cancer drug, says a new study by Tulane University School of Medicine cancer researchers.

25 Jul 2014

Signaling pathway may help explain why body clocks of people with bipolar disease

Alterations in a cellular signaling pathway called cAMP-CREB may help explain why the body clocks of people with bipolar disease are out of sync, according to a new European Journal of Neuroscience study.

17 Jun 2014

Vanda’s HETLIOZ MAA for Non-24-Hour Sleep-Wake Disorder accepted for evaluation by the EMA

Vanda Pharmaceuticals Inc. announced today that its Marketing Authorization Application (MAA) for oral HETLIOZ™ (tasimelteon) capsules has been accepted for evaluation by the European Medicines Agency (EMA) for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24).

3 Jun 2014

McGill researchers show melatonin supplements may make bones stronger in old rats

McGill researchers have shown that melatonin supplements may make bones stronger in old rats. This suggests a possible avenue for the prevention of osteoporosis.

27 May 2014

USPTO grants two additional patents to SeroVital-hgh formula

SeroVital®-hgh, the "Fountain of Youth" Formula everyone's talking about, has been making headlines ever since a group of some of the most renowned researchers in the world revealed that this oral compound is actually capable of increasing mean, endogenous, serum (blood) human growth hormone (hGH) levels by 682%. Experts everywhere — from dermatologists and obesity researchers to women's healthcare providers and even the famed Dr. Oz himself — began paying attention to this groundbreaking formula.

19 May 2014

Nearly six in ten don't get enough sleep, says online survey

New online research, conducted to coincide with the publication of Professor Richard Wiseman's latest book Night School, suggests that nearly six in ten (59%) of adults in Britain - over 28 million people - are now sleep deprived and getting seven hours or less sleep each night.

4 Apr 2014

Circadian dysfunction blamed for sleepiness in PD patients

Patients with Parkinson’s disease, particularly those with excessive daytime sleepiness, have reduced melatonin levels and amplitude of the melatonin circadian rhythm, research shows.

6 Mar 2014

Study investigates possible links between sleep and omega-3 DHA fatty acid status in healthy children

A randomised placebo-controlled study by the University of Oxford suggests that higher levels of omega-3 DHA, the group of long-chain fatty acids found in algae and seafood, are associated with better sleep.

6 Mar 2014

Tips to ease daylight saving time transition

Daylight saving time begins at 2 a.m. on Sunday, March 9, bringing more sunshine in the evenings at the price of an hour of sleep. Vanderbilt Sleep Disorders Center specialist Kelly Brown, M.D., says a little extra planning can alleviate that groggy feeling that often accompanies the time change.

6 Mar 2014

Researcher tackles new way to slow down and perhaps prevent preterm labor

A Florida State University researcher is tackling a new and inventive way to slow down and perhaps prevent preterm labor.

6 Feb 2014

CICC signs agreement with BEUB to distribute nutriceutical products

On January 27, 2014, China Internet Cafe Holdings Group Inc. ("CICC" or the "Company") (OTCQB: CICC), a leading chain of Internet cafes in the People's Republic of China, announced that it signed a distribution agreement with Beijing Eastern Union Biopharmaceuticals, Ltd.

31 Jan 2014

Study shows melatonin hormone may inhibit tumor growth and cell production

An early stage study shows melatonin - a hormone that regulates the body's sleep and awake cycles - may have the potential to help slow the growth of certain breast cancer tumors, according to researchers from Henry Ford Hospital in Detroit and Foundation for Research Support of the State of S-o Paulo.

28 Jan 2014

Melatonin may influence prostate cancer stage

A man’s risk of developing advanced stage prostate cancer may depend on how much melatonin he produces while he is asleep, suggest researchers.

23 Jan 2014

Higher levels of melatonin may lower risk for developing advanced prostate cancer

Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.

19 Jan 2014

Melatonin plays major role in pain transmission

Accumulating research indicates that melatonin has a major role in pain transmission and has an ultra-sensitizing effect. Dr. Fang Huang and colleagues from Sun Yat-sen University in China for the first time located the distribution of melatonin receptor 1 in the caudal spinal trigeminal nucleus.

31 Dec 2013

Toddlers’ bedtime resistance may contribute to sleep problems

The bedtime you select for your toddler may be out of sync with his or her internal body clock, which can contribute to difficulties for youngsters attempting to settle in for the night, according to a new University of Colorado Boulder study.

17 Dec 2013

Study: Social ties more important than biological development as predictors of teen sleep behaviors

Medical researchers point to developmental factors, specifically the decline of the sleep-inducing hormone melatonin, as an explanation for why children get less sleep as they become teenagers.

5 Dec 2013

Study finds way to regulate sleep patterns of children with brain disorders

For parents of children with brain disorders or visual impairment, nights can be long and frustrating, leading to even more difficult days as exhaustion takes hold.

29 Nov 2013

FDA Advisory Committee votes in favor of Vanda's tasimelteon NDA for Non-24-Hour Disorder

Vanda Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee voted overwhelmingly to recommend the approval of Vanda's New Drug Application for tasimelteon, proposed tradename HETLIOZ™, for the treatment of Non-24-Hour Disorder (Non-24) in the totally blind.

15 Nov 2013

School-year bedtimes impact teens’ academic, social and emotional development

Teenagers who go to bed late during the school year are more prone to academic and emotional difficulties in the long run, compared to their earlier-to-bed counterparts, according to a new study from the University of California, Berkeley.

11 Nov 2013